Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Dermatology Drug Market Size Analysis from 2022 to 2027

1.5.1 Global Dermatology Drug Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Dermatology Drug Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Dermatology Drug Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Dermatology Drug Industry Impact

Chapter 2 Global Dermatology Drug Competition by Types, Applications, and Top Regions and Countries

2.1 Global Dermatology Drug (Volume and Value) by Type

2.1.1 Global Dermatology Drug Consumption and Market Share by Type (2016-2021)

2.1.2 Global Dermatology Drug Revenue and Market Share by Type (2016-2021)

2.2 Global Dermatology Drug (Volume and Value) by Application

2.2.1 Global Dermatology Drug Consumption and Market Share by Application (2016-2021)

2.2.2 Global Dermatology Drug Revenue and Market Share by Application (2016-2021)

2.3 Global Dermatology Drug (Volume and Value) by Regions

2.3.1 Global Dermatology Drug Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Dermatology Drug Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Dermatology Drug Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Dermatology Drug Consumption by Regions (2016-2021)

4.2 North America Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

4.10 South America Dermatology Drug Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Dermatology Drug Market Analysis

5.1 North America Dermatology Drug Consumption and Value Analysis

5.1.1 North America Dermatology Drug Market Under COVID-19

5.2 North America Dermatology Drug Consumption Volume by Types

5.3 North America Dermatology Drug Consumption Structure by Application

5.4 North America Dermatology Drug Consumption by Top Countries

5.4.1 United States Dermatology Drug Consumption Volume from 2016 to 2021

5.4.2 Canada Dermatology Drug Consumption Volume from 2016 to 2021

5.4.3 Mexico Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 6 East Asia Dermatology Drug Market Analysis

6.1 East Asia Dermatology Drug Consumption and Value Analysis

6.1.1 East Asia Dermatology Drug Market Under COVID-19

6.2 East Asia Dermatology Drug Consumption Volume by Types

6.3 East Asia Dermatology Drug Consumption Structure by Application

6.4 East Asia Dermatology Drug Consumption by Top Countries

6.4.1 China Dermatology Drug Consumption Volume from 2016 to 2021

6.4.2 Japan Dermatology Drug Consumption Volume from 2016 to 2021

6.4.3 South Korea Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 7 Europe Dermatology Drug Market Analysis

7.1 Europe Dermatology Drug Consumption and Value Analysis

7.1.1 Europe Dermatology Drug Market Under COVID-19

7.2 Europe Dermatology Drug Consumption Volume by Types

7.3 Europe Dermatology Drug Consumption Structure by Application

7.4 Europe Dermatology Drug Consumption by Top Countries

7.4.1 Germany Dermatology Drug Consumption Volume from 2016 to 2021

7.4.2 UK Dermatology Drug Consumption Volume from 2016 to 2021

7.4.3 France Dermatology Drug Consumption Volume from 2016 to 2021

7.4.4 Italy Dermatology Drug Consumption Volume from 2016 to 2021

7.4.5 Russia Dermatology Drug Consumption Volume from 2016 to 2021

7.4.6 Spain Dermatology Drug Consumption Volume from 2016 to 2021

7.4.7 Netherlands Dermatology Drug Consumption Volume from 2016 to 2021

7.4.8 Switzerland Dermatology Drug Consumption Volume from 2016 to 2021

7.4.9 Poland Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 8 South Asia Dermatology Drug Market Analysis

8.1 South Asia Dermatology Drug Consumption and Value Analysis

8.1.1 South Asia Dermatology Drug Market Under COVID-19

8.2 South Asia Dermatology Drug Consumption Volume by Types

8.3 South Asia Dermatology Drug Consumption Structure by Application

8.4 South Asia Dermatology Drug Consumption by Top Countries

8.4.1 India Dermatology Drug Consumption Volume from 2016 to 2021

8.4.2 Pakistan Dermatology Drug Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Dermatology Drug Market Analysis

9.1 Southeast Asia Dermatology Drug Consumption and Value Analysis

9.1.1 Southeast Asia Dermatology Drug Market Under COVID-19

9.2 Southeast Asia Dermatology Drug Consumption Volume by Types

9.3 Southeast Asia Dermatology Drug Consumption Structure by Application

9.4 Southeast Asia Dermatology Drug Consumption by Top Countries

9.4.1 Indonesia Dermatology Drug Consumption Volume from 2016 to 2021

9.4.2 Thailand Dermatology Drug Consumption Volume from 2016 to 2021

9.4.3 Singapore Dermatology Drug Consumption Volume from 2016 to 2021

9.4.4 Malaysia Dermatology Drug Consumption Volume from 2016 to 2021

9.4.5 Philippines Dermatology Drug Consumption Volume from 2016 to 2021

9.4.6 Vietnam Dermatology Drug Consumption Volume from 2016 to 2021

9.4.7 Myanmar Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 10 Middle East Dermatology Drug Market Analysis

10.1 Middle East Dermatology Drug Consumption and Value Analysis

10.1.1 Middle East Dermatology Drug Market Under COVID-19

10.2 Middle East Dermatology Drug Consumption Volume by Types

10.3 Middle East Dermatology Drug Consumption Structure by Application

10.4 Middle East Dermatology Drug Consumption by Top Countries

10.4.1 Turkey Dermatology Drug Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Dermatology Drug Consumption Volume from 2016 to 2021

10.4.3 Iran Dermatology Drug Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Dermatology Drug Consumption Volume from 2016 to 2021

10.4.5 Israel Dermatology Drug Consumption Volume from 2016 to 2021

10.4.6 Iraq Dermatology Drug Consumption Volume from 2016 to 2021

10.4.7 Qatar Dermatology Drug Consumption Volume from 2016 to 2021

10.4.8 Kuwait Dermatology Drug Consumption Volume from 2016 to 2021

10.4.9 Oman Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 11 Africa Dermatology Drug Market Analysis

11.1 Africa Dermatology Drug Consumption and Value Analysis

11.1.1 Africa Dermatology Drug Market Under COVID-19

11.2 Africa Dermatology Drug Consumption Volume by Types

11.3 Africa Dermatology Drug Consumption Structure by Application

11.4 Africa Dermatology Drug Consumption by Top Countries

11.4.1 Nigeria Dermatology Drug Consumption Volume from 2016 to 2021

11.4.2 South Africa Dermatology Drug Consumption Volume from 2016 to 2021

11.4.3 Egypt Dermatology Drug Consumption Volume from 2016 to 2021

11.4.4 Algeria Dermatology Drug Consumption Volume from 2016 to 2021

11.4.5 Morocco Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 12 Oceania Dermatology Drug Market Analysis

12.1 Oceania Dermatology Drug Consumption and Value Analysis

12.2 Oceania Dermatology Drug Consumption Volume by Types

12.3 Oceania Dermatology Drug Consumption Structure by Application

12.4 Oceania Dermatology Drug Consumption by Top Countries

12.4.1 Australia Dermatology Drug Consumption Volume from 2016 to 2021

12.4.2 New Zealand Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 13 South America Dermatology Drug Market Analysis

13.1 South America Dermatology Drug Consumption and Value Analysis

13.1.1 South America Dermatology Drug Market Under COVID-19

13.2 South America Dermatology Drug Consumption Volume by Types

13.3 South America Dermatology Drug Consumption Structure by Application

13.4 South America Dermatology Drug Consumption Volume by Major Countries

13.4.1 Brazil Dermatology Drug Consumption Volume from 2016 to 2021

13.4.2 Argentina Dermatology Drug Consumption Volume from 2016 to 2021

13.4.3 Columbia Dermatology Drug Consumption Volume from 2016 to 2021

13.4.4 Chile Dermatology Drug Consumption Volume from 2016 to 2021

13.4.5 Venezuela Dermatology Drug Consumption Volume from 2016 to 2021

13.4.6 Peru Dermatology Drug Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Dermatology Drug Consumption Volume from 2016 to 2021

13.4.8 Ecuador Dermatology Drug Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Dermatology Drug Business

14.1 AbbVie

14.1.1 AbbVie Company Profile

14.1.2 AbbVie Dermatology Drug Product Specification

14.1.3 AbbVie Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Merz Pharma

14.2.1 Merz Pharma Company Profile

14.2.2 Merz Pharma Dermatology Drug Product Specification

14.2.3 Merz Pharma Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Galderma

14.3.1 Galderma Company Profile

14.3.2 Galderma Dermatology Drug Product Specification

14.3.3 Galderma Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Johnson & Johnson

14.4.1 Johnson & Johnson Company Profile

14.4.2 Johnson & Johnson Dermatology Drug Product Specification

14.4.3 Johnson & Johnson Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Pfizer

14.5.1 Pfizer Company Profile

14.5.2 Pfizer Dermatology Drug Product Specification

14.5.3 Pfizer Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Bayer

14.6.1 Bayer Company Profile

14.6.2 Bayer Dermatology Drug Product Specification

14.6.3 Bayer Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 LEO Pharma

14.7.1 LEO Pharma Company Profile

14.7.2 LEO Pharma Dermatology Drug Product Specification

14.7.3 LEO Pharma Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Novartis

14.8.1 Novartis Company Profile

14.8.2 Novartis Dermatology Drug Product Specification

14.8.3 Novartis Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Bristol-Myers Squibb

14.9.1 Bristol-Myers Squibb Company Profile

14.9.2 Bristol-Myers Squibb Dermatology Drug Product Specification

14.9.3 Bristol-Myers Squibb Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Valeant

14.10.1 Valeant Company Profile

14.10.2 Valeant Dermatology Drug Product Specification

14.10.3 Valeant Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 GlaxoSmithKline

14.11.1 GlaxoSmithKline Company Profile

14.11.2 GlaxoSmithKline Dermatology Drug Product Specification

14.11.3 GlaxoSmithKline Dermatology Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Dermatology Drug Market Forecast (2022-2027)

15.1 Global Dermatology Drug Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Dermatology Drug Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Dermatology Drug Value and Growth Rate Forecast (2022-2027)

15.2 Global Dermatology Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Dermatology Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Dermatology Drug Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Dermatology Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Dermatology Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Dermatology Drug Consumption Forecast by Type (2022-2027)

15.3.2 Global Dermatology Drug Revenue Forecast by Type (2022-2027)

15.3.3 Global Dermatology Drug Price Forecast by Type (2022-2027)

15.4 Global Dermatology Drug Consumption Volume Forecast by Application (2022-2027)

15.5 Dermatology Drug Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology